The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

A pooled gender based analysis comparing the XIENCE V® everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis

EuroIntervention 2010;5:788-794.

1. Escorts Heart Institute & Research Centre, New Delhi, India; 2. Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 3. Columbia University Medical Center, New York, NY, USA; 4. Heart Center of IN, Indianapolis, IN, USA; 5. Abbott Vasc

Aims: To assess the safety and efficacy of the XIENCE V everolimus-eluting stent (EES) compared to the TAXUS paclitaxel-eluting stent (PES) in women at two years.

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Sex-related differences in patients undergoing percutaneous unprotected left main stenting